The ReTAVI Prospective Observational Registry

Inclusion Criteria:

Consecutive patients fulfilling the following criteria:

1. Consenting adult patient (≥18 years)

2. Procedural success of the first TAVI

3. TAVI device failure of the index THV, irrespective of SVD severity

4. Intention to treat the patient with a redo-TAVI procedure (SAPIEN family THV)

5. The Local Heart Team and the Case Review Board consider the patient suitable andindicated for elective redo-TAVI

6. Patient is scheduled to undergo a 30 Day and 12 Months follow-up (both visits takingplace in the hospital)

Exclusion Criteria:

1. Patients without signed informed consent / data protection statement (according torequirements of local IRB/IEC)

2. Life expectancy below 12 months

3. Patients with largely incomplete data with respect to the aims of the project

4. Pregnant women at the time of the redo-TAVI

Note: For all patients included a defined core data set will be collected prospectively. All patients being in accordance with above stated inclusion and exclusion criteria and receiving a balloon-expandable transcatheter aortic valve will be included in the extended documentation.